14:30 CET

ASH 2017 Summary webcast

Oncopeptides has a press conference at 14.30 CET, December 13.

To attend, please call the following numbers:

UK: +442030089801
SE: +46856642662
US: +18557532235

The conference call will also be streamed via the link:

https://tv.streamfabriken.com/2017-12-13-oncopeptides-pressconference

Upcoming events

Silent Period

-

FDA - Oncologic Drugs Advisory Committee (ODAC) Meeting

The US Food and Drug Administration, FDA, has announced a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (ODAC), on October 28, 2021 concerning Oncopeptides’ product Pepaxto. The information is in line with the FDA safety alert on July 28, where the FDA stated that a public meeting may be hold to discuss the safety findings from the OCEAN study.

Interim Report Q3 2021

08:00 CET

Silent Period

-

Year-end report 2021

08:00 CET

Silent Period

-

Silent Period

-